Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 92

1.

Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development.

Vishwakarma BA, Nguyen N, Makishima H, Hosono N, Gudmundsson KO, Negi V, Oakley K, Han Y, Przychodzen B, Maciejewski JP, Du Y.

Leukemia. 2015 Jul 24. doi: 10.1038/leu.2015.200. [Epub ahead of print]

PMID:
26205084
2.

Analyzing gene function in adult long-term hematopoietic stem cells using the interferon inducible Mx1-Cre mouse system.

Gudmundsson KO, Oakley K, Han Y, Du Y.

Methods Mol Biol. 2014;1194:313-25. doi: 10.1007/978-1-4939-1215-5_17.

PMID:
25064111
3.

[Age and earnings of specialists[Editorial]].

Gudmundsson K.

Laeknabladid. 2013 Nov;99(11):495. Icelandic. No abstract available.

PMID:
24287737
4.

Cryoablation of substrates adjacent to the atrioventricular node: acute and long-term safety of 1303 ablation procedures.

Insulander P, Bastani H, Braunschweig F, Drca N, Gudmundsson K, Kennebäck G, Sadigh B, Schwieler J, Tapanainen J, Jensen-Urstad M.

Europace. 2014 Feb;16(2):271-6. doi: 10.1093/europace/eut215. Epub 2013 Jul 12.

5.

Somatic SETBP1 mutations in myeloid malignancies.

Makishima H, Yoshida K, Nguyen N, Przychodzen B, Sanada M, Okuno Y, Ng KP, Gudmundsson KO, Vishwakarma BA, Jerez A, Gomez-Segui I, Takahashi M, Shiraishi Y, Nagata Y, Guinta K, Mori H, Sekeres MA, Chiba K, Tanaka H, Muramatsu H, Sakaguchi H, Paquette RL, McDevitt MA, Kojima S, Saunthararajah Y, Miyano S, Shih LY, Du Y, Ogawa S, Maciejewski JP.

Nat Genet. 2013 Aug;45(8):942-6. doi: 10.1038/ng.2696. Epub 2013 Jul 7.

6.

Association of Morbus Ledderhose with Dupuytren's contracture.

Gudmundsson KG, Jónsson T, Arngrímsson R.

Foot Ankle Int. 2013 Jun;34(6):841-5. doi: 10.1177/1071100713475352. Epub 2013 Feb 5.

PMID:
23386754
7.

Association of HLA-DRB1*01 with Dupuytren's disease.

Jónsson T, Gudmundsson KG, Bjarnadóttir K, Hjálmarsdótti IB, Gudmundsson S, Arngrímsson R.

Scand J Rheumatol. 2013;42(1):45-7. doi: 10.3109/03009742.2012.713982. Epub 2012 Sep 20.

PMID:
22991974
8.

Transplantation of mouse fetal liver cells for analyzing the function of hematopoietic stem and progenitor cells.

Gudmundsson KO, Stull SW, Keller JR.

Methods Mol Biol. 2012;879:123-33. doi: 10.1007/978-1-61779-815-3_8.

PMID:
22610557
9.

Setbp1 promotes the self-renewal of murine myeloid progenitors via activation of Hoxa9 and Hoxa10.

Oakley K, Han Y, Vishwakarma BA, Chu S, Bhatia R, Gudmundsson KO, Keller J, Chen X, Vasko V, Jenkins NA, Copeland NG, Du Y.

Blood. 2012 Jun 21;119(25):6099-108. doi: 10.1182/blood-2011-10-388710. Epub 2012 May 7.

10.

Midsummer Eve in Sweden: a natural fluid challenge in patients with heart failure.

Gudmundsson K, Lyngå P, Karlsson H, Rosenqvist M, Braunschweig F.

Eur J Heart Fail. 2011 Nov;13(11):1172-7. doi: 10.1093/eurjhf/hfr124. Epub 2011 Oct 5.

PMID:
21979992
11.

RapGEF2 is essential for embryonic hematopoiesis but dispensable for adult hematopoiesis.

Satyanarayana A, Gudmundsson KO, Chen X, Coppola V, Tessarollo L, Keller JR, Hou SX.

Blood. 2010 Oct 21;116(16):2921-31. doi: 10.1182/blood-2010-01-262964. Epub 2010 Jul 1.

12.

Synthesis and SAR of novel isoquinoline CXCR4 antagonists with potent anti-HIV activity.

Miller JF, Gudmundsson KS, D'Aurora Richardson L, Jenkinson S, Spaltenstein A, Thomson M, Wheelan P.

Bioorg Med Chem Lett. 2010 May 15;20(10):3026-30.

PMID:
20443225
13.

Novel N-substituted benzimidazole CXCR4 antagonists as potential anti-HIV agents.

Miller JF, Turner EM, Gudmundsson KS, Jenkinson S, Spaltenstein A, Thomson M, Wheelan P.

Bioorg Med Chem Lett. 2010 Apr 1;20(7):2125-8. doi: 10.1016/j.bmcl.2010.02.053. Epub 2010 Feb 14.

PMID:
20207537
14.

Synthesis of a novel tricyclic 1,2,3,4,4a,5,6,10b-octahydro-1,10-phenanthroline ring system and CXCR4 antagonists with potent activity against HIV-1.

Catalano JG, Gudmundsson KS, Svolto A, Boggs SD, Miller JF, Spaltenstein A, Thomson M, Wheelan P, Minick DJ, Phelps DP, Jenkinson S.

Bioorg Med Chem Lett. 2010 Apr 1;20(7):2186-90. doi: 10.1016/j.bmcl.2010.02.030. Epub 2010 Feb 12.

PMID:
20194023
15.

Challenges with advanced therapy medicinal products and how to meet them.

Committee for Advanced Therapies (CAT); CAT Scientific Secretariat, Schneider CK, Salmikangas P, Jilma B, Flamion B, Todorova LR, Paphitou A, Haunerova I, Maimets T, Trouvin JH, Flory E, Tsiftsoglou A, Sarkadi B, Gudmundsson K, O'Donovan M, Migliaccio G, Ancāns J, Maciulaitis R, Robert JL, Samuel A, Ovelgönne JH, Hystad M, Fal AM, Lima BS, Moraru AS, Turcáni P, Zorec R, Ruiz S, Akerblom L, Narayanan G, Kent A, Bignami F, Dickson JG, Niederwieser D, Figuerola-Santos MA, Reischl IG, Beuneu C, Georgiev R, Vassiliou M, Pychova A, Clausen M, Methuen T, Lucas S, Schüssler-Lenz M, Kokkas V, Buzás Z, MacAleenan N, Galli MC, Linē A, Gulbinovic J, Berchem G, Fraczek M, Menezes-Ferreira M, Vilceanu N, Hrubisko M, Marinko P, Timón M, Cheng W, Crosbie GA, Meade N, di Paola ML, VandenDriessche T, Ljungman P, D'Apote L, Oliver-Diaz O, Büttel I, Celis P.

Nat Rev Drug Discov. 2010 Mar;9(3):195-201. doi: 10.1038/nrd3052.

PMID:
20190786
16.

Thymic development beyond beta-selection requires phosphatidylinositol 3-kinase activation by CXCR4.

Janas ML, Varano G, Gudmundsson K, Noda M, Nagasawa T, Turner M.

J Exp Med. 2010 Jan 18;207(1):247-61. doi: 10.1084/jem.20091430. Epub 2009 Dec 28.

17.

Blockade of X4-tropic HIV-1 cellular entry by GSK812397, a potent noncompetitive CXCR4 receptor antagonist.

Jenkinson S, Thomson M, McCoy D, Edelstein M, Danehower S, Lawrence W, Wheelan P, Spaltenstein A, Gudmundsson K.

Antimicrob Agents Chemother. 2010 Feb;54(2):817-24. doi: 10.1128/AAC.01293-09. Epub 2009 Nov 30.

18.

Substituted tetrahydro-beta-carbolines as potential agents for the treatment of human papillomavirus infection.

Miller JF, Turner EM, Sherrill RG, Gudmundsson K, Spaltenstein A, Sethna P, Brown KW, Harvey R, Romines KR, Golden P.

Bioorg Med Chem Lett. 2010 Jan 1;20(1):256-9. doi: 10.1016/j.bmcl.2009.10.123. Epub 2009 Oct 30.

PMID:
19914830
19.

Imidazopyridine-5,6,7,8-tetrahydro-8-quinolinamine derivatives with potent activity against HIV-1.

Gudmundsson KS, Boggs SD, Catalano JG, Svolto A, Spaltenstein A, Thomson M, Wheelan P, Jenkinson S.

Bioorg Med Chem Lett. 2009 Nov 15;19(22):6399-403. doi: 10.1016/j.bmcl.2009.09.056. Epub 2009 Sep 19.

PMID:
19818609
20.

Pyrazolopyrimidines and pyrazolotriazines with potent activity against herpesviruses.

Gudmundsson KS, Johns BA, Weatherhead J.

Bioorg Med Chem Lett. 2009 Oct 1;19(19):5689-92. doi: 10.1016/j.bmcl.2009.08.009. Epub 2009 Aug 7.

PMID:
19700316
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk